The MVP Act amends Medicaid to formalize value-based purchasing arrangements for drugs and biological products.

The MVP Act amends title XIX of the Social Security Act to formalize value-based purchasing arrangements for drugs and biological products under Medicaid. It codifies these arrangements and mandates the Comptroller General to study their impact on patient access, outcomes, and costs. The bill also requires the Secretary of Health and Human Services to issue guidance to State Medicaid agencies on entering into such arrangements. Additionally, it amends the calculation of average sales price under Medicare and makes exceptions under the antikickback statute.

The MVP Act amends Medicaid to formalize value-based purchasing arrangements for drugs and biological products.

The MVP Act amends title XIX of the Social Security Act to formalize value-based purchasing arrangements for drugs and biological products under Medicaid. It codifies these arrangements and mandates the Comptroller General to study their impact on patient access, outcomes, and costs. The bill also requires the Secretary of Health and Human Services to issue guidance to State Medicaid agencies on entering into such arrangements. Additionally, it amends the calculation of average sales price under Medicare and makes exceptions under the antikickback statute.